Literature DB >> 13911447

Adjuvant-antigen relationships in the production of experimental "allergic" encephalomyelitis in the guinea pig.

C M SHAW, E C ALVORD, W J FAHLBERG, M W KIES.   

Abstract

Quantitative relationships between the amounts of encephalitogenic neural tissue and mycobacterial adjuvant are presented for the guinea pig, for comparison with similar results obtained in the mouse and presented in an accompanying paper by Lee and Schneider (27). Definite threshold amounts of both neural encephalitogenic and mycobacterial adjuvant can be defined. With the proper amounts of each component, 100 per cent of guinea pigs can be made to develop EAE, 97 per cent dying of it, and over 50 per cent becoming paralyzed by the 12th day after challenge. With moderate amounts of encephalitogen the severity and incidence of EAE can be very great, but this encephalitogenic potential can be masked if large amounts of mycobacteria are employed. The mechanism of this masking effect by excess adjuvant is not known, but speculation centers upon the possibility of competition of antigens of the mycobacteria at the expense of those of the encephalitogen.

Entities:  

Keywords:  ENCEPHALOMYELITIS/experimental

Mesh:

Substances:

Year:  1962        PMID: 13911447      PMCID: PMC2137483          DOI: 10.1084/jem.115.1.169

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Neural tissue and pulmonary lesions in normal and irradiated rats injected with homogenized homologous lung tissue mixed with Freund's adjuvant.

Authors:  N ALLEGRETTI; B VITALE
Journal:  Nature       Date:  1961-02-25       Impact factor: 49.962

2.  Studies on the mechanism of altered susceptibility to experimental allergic encephalomyelitis.

Authors:  S LEVINE; E J WENK
Journal:  Am J Pathol       Date:  1961-10       Impact factor: 4.307

3.  [Role of killed tubercle bacillus in the pathogenesis of so-called allergic encephalomyelitis induced by brain extract plus Freund's adjuvants].

Authors:  N CONSTANTINESCO; T HORNET; N BIRZU; O ZAVATE; I PENCEA; S RUSAN
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-01

4.  A demyelinating disease of the brain produced by injection of liver or liver proteolipid.

Authors:  C TAL; A J BEHAR
Journal:  J Pathol Bacteriol       Date:  1958-10

5.  Experimental allergic encephalomyelitis after the excision of the injection site of antigen-adjuvant emulsion.

Authors:  J FREUND; M M LIPTON
Journal:  J Immunol       Date:  1955-12       Impact factor: 5.422

6.  An experimental demyelinative disease in the Syrian hamster.

Authors:  C TAL; A LAUFER; A J BEHAR
Journal:  Br J Exp Pathol       Date:  1958-04

7.  The mode of action of immunologic adjuvants.

Authors:  J FREUND
Journal:  Bibl Tuberc       Date:  1956

8.  The efficacy of the intracutaneous route of injection and the susceptibility of the Hartley strain of guinea pigs in experimental allergic encephalitis.

Authors:  M M LIPTON; J FREUND
Journal:  J Immunol       Date:  1953-03       Impact factor: 5.422

9.  Allergic encephalomyelitis in the rat induced by the intracutaneous injection of central nervous system tissue and adjuvants.

Authors:  M M LIPTON; J FREUND
Journal:  J Immunol       Date:  1953-08       Impact factor: 5.422

10.  Rapid induction of allergic encephalomyelitis in rats without the use of mycobacteria.

Authors:  J BELL; P Y PATERSON
Journal:  Science       Date:  1960-05-13       Impact factor: 47.728

View more
  10 in total

Review 1.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

2.  [Experimental allergic chorioretinitis in rabbits by immunization to homologous retina in adjuvant. I. Clinical studies (author's transl)].

Authors:  K D Schröder; W Meyer; E Hempel; S Tilgner
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974

3.  Immunohistological evidence of perivascular localization of basic protein in early development of experimental allergic encephalomyelitis.

Authors:  J Simon; A P Anzil
Journal:  Acta Neuropathol       Date:  1974-02-07       Impact factor: 17.088

4.  Relationship between the incidence of experimental allergic encephalomyelitis and the development of adjuvant disease.

Authors:  N Allegretti; B Vitale
Journal:  Immunology       Date:  1965-07       Impact factor: 7.397

5.  Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.

Authors:  T J Meyer; I Azuma; E E Ribi
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

6.  Murine thyroiditis. 3. Influence of syngeneic and allogeneic thyroid antigen on induction of the disease.

Authors:  A O Vladutiu; N R Rose
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

7.  Adjuvanticity and delayed-type hypersensitivity by Bacillus Calmette-Guérin (BCG).

Authors:  I J Hiu; J L Amiel
Journal:  Experientia       Date:  1972-08-15

8.  Prevention of experimental allergic encephalomyelitis (EAE) by vitamin C deprivation.

Authors:  P S MUELLER; M W KIES; E C ALVORD; C M SHAW
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

9.  Antibody studies in rabbit encephalomyelitis induced by a water-soluble protein fraction of rabbit cord.

Authors:  R F KIBLER; A E BARNES
Journal:  J Exp Med       Date:  1962-12-01       Impact factor: 14.307

10.  Enhancement of encephalomyeloradiculitis in mice sensitized with spinal cord tissue and infected with lactate dehydrogenase-elevating virus.

Authors:  W G Stroop; M A Brinton
Journal:  J Neuroimmunol       Date:  1985-05       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.